Literature DB >> 11747656

Telemedicine in Kansas: the successes and the challenges.

G C Doolittle1.   

Abstract

Based on our experience of telemedicine in Kansas, we have identified several key factors in the success of a telemedicine practice. Very early in any project, it is important to bring together all participants (especially the physicians who are expected to refer patients) to define the need, outline specific goals, analyse and test the technology, and develop a plan for the implementation. As with traditional health-care, many partners must come together, including primary-care practitioners willing to shoulder day-to-day responsibility for management of complex patients, nurses with special expertise and consultants willing to work with a remote team using telemedicine. These individuals must accept the challenges and appreciate the rewards of working in a different practice model, in which communication and interdependence are critical for success. The telemedicine consultant is only as good as the local health-care team. The technology itself is only a small part of the equation.

Entities:  

Mesh:

Year:  2001        PMID: 11747656     DOI: 10.1258/1357633011937092

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  3 in total

1.  The Impact of Prospective Telemedicine Implementation in the Management of Childhood Acute Lymphoblastic Leukemia in Recife, Brazil.

Authors:  Francisco Pedrosa; Faisal Shaikh; Gaston Rivera; Raul Ribeiro; Ibrahim Qaddoumi
Journal:  Telemed J E Health       Date:  2017-04-19       Impact factor: 3.536

2.  Cardiovascular risk reduction via telehealth: a feasibility study.

Authors:  Anne M PausJenssen; Betty Anne Spooner; Merne P Wilson; Thomas W Wilson
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

3.  Characteristics of successfully implemented telemedical applications.

Authors:  Aud Obstfelder; Kjersti H Engeseth; Rolf Wynn
Journal:  Implement Sci       Date:  2007-07-27       Impact factor: 7.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.